Chan Cheah, MD, University of Western Australia, discusses treatment for patients with nodular lymphocyte predominant Hodgkin lymphoma.

Nodular lymphocyte predominant Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma, Cheah states. This rare subtype has a tendency towards late relapse.

Previously nodular lymphocyte predominant Hodgkin lymphoma was treated with the same chemotherapy regimens as Hodgkin lymphoma. However, due to the biological differences superior outcomes might be achieved by using a non-Hodgkin lymphoma protocol, explains Cheah.

More from the International Conference on Malignant Lymphoma

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Dr. Cheah on Treatment for Nodular Lymphocyte Predominant Hodgkin Lymphoma